Pediatric Epilepsy Study

NCT00050934 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Epilepsies, Partial

Interventions

DRUG: oxcarbazepine

Sponsor

Novartis Pharmaceuticals